NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,517,000 | +107.7% | 14,548 | +33.6% | 0.01% | +75.0% |
| Q3 2020 | $1,212,000 | +72.9% | 10,892 | -7.8% | 0.00% | +33.3% |
| Q2 2020 | $701,000 | -31.7% | 11,819 | -22.4% | 0.00% | -40.0% |
| Q1 2020 | $1,026,000 | -14.2% | 15,237 | +7.4% | 0.01% | +25.0% |
| Q4 2019 | $1,196,000 | +14.8% | 14,185 | +1.8% | 0.00% | 0.0% |
| Q3 2019 | $1,042,000 | +62.3% | 13,933 | +37.2% | 0.00% | +33.3% |
| Q2 2019 | $642,000 | +57.4% | 10,157 | +19.9% | 0.00% | +50.0% |
| Q1 2019 | $408,000 | +58.8% | 8,473 | +10.3% | 0.00% | +100.0% |
| Q4 2018 | $257,000 | -12.0% | 7,681 | +37.9% | 0.00% | 0.0% |
| Q3 2018 | $292,000 | +81.4% | 5,568 | -72.8% | 0.00% | 0.0% |
| Q4 2016 | $161,000 | – | 20,503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |